Multiplex Detection Immunoassays Market Size to Hit USD 3.7 Bn by 2030

October 17, 2022 |

5 min read

According to Nova one advisor, the global Multiplex Detection Immunoassays market was valued at USD 1.8 billion in 2020 and it is expected to hit around USD 3.7 billion by 2030 with a CAGR of 9.7% during the forecast period 2022 to 2030.

According to Nova one advisor, the global Multiplex Detection Immunoassays market was valued at USD 1.8 billion in 2020 and it is expected to hit around USD 3.7 billion by 2030 with a CAGR of 9.7% during the forecast period 2022 to 2030.

Request Free Sample of This Report@ https://www.novaoneadvisor.com/report/sample/4216

Ask here for more customization study@ https://www.novaoneadvisor.com/report/customization/4216

Multiplex immunoassays provide sufficient analytical performance to evaluate serum biomarkers that complement each other in the detection of a larger number of patient samples. The use of differentially detectable beads of different regions enables simultaneous identification and quantification of multiple analytes in the same sample allowing the individual immunoassays to be multiplexed.

In terms of assay type, the global multiplex detection immunoassays market has been bifurcated into planar assay and bead-based assay. The planar assay segment has been split into blends protein arrays (multiplexed ELISA) and antibody arrays. The bead-based assay sub-segment has been segregated into magnetic bead-based and non-magnetic bead-based. The planar assay segment accounted for prominent share of the global multiplex detection immunoassays market in 2020. The segment is anticipated to expand at a high CAGR during the forecast period, owing to rise in the need and demand for diagnosis by patients.

Based on technique, the global multiplex detection immunoassays market has been divided into nucleic acid-based techniques, protein-based techniques, and biosensor-based techniques. The protein-based techniques segment held a significant share of the global multiplex detection immunoassays market in 2020. In terms of application, the global multiplex detection immunoassays market has been classified into disease testing, food contamination testing, research & development, and veterinary disease testing. The research & development segment accounted for major share of the global multiplex detection immunoassays market in 2020.

Report Highlights	Details
Market Size	US$ 1.8 Billion by 2027
Growth Rate	CAGR of 9.7% From 2021 to 2027
Base Year	2020
Historic Data	2017 to 2020
Forecast Period	2021 to 2027
Segments Covered	Assay Type,Technique,Application,End User
Regional Scope	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)

Rise In Demand For Clinical Diagnosis Applications To Propel Market Growth

Multiplex detection immunoassays are increasingly being used in a wide range of applications, including infectious disease testing, food contamination testing, veterinary disease testing, and R&D activities. The increasing demand for multiplex detection immunoassays for clinical diagnosis is expected to accelerate the development of multiplex detection immunoassays in the upcoming years– a factor that is set to fuel the growth of the market for global multiplex detection immunoassays during the assessment period. Prosthetic joint replacements are primarily used to enhance the quality of life, restore the joint function, and improve mobility. Although prosthetic joint replacement is a globally accepted treatment, prosthetic joint infection is one of the major causes of knee arthroplasties, which makes early diagnosis critical. This is set to drive the demand for multiplex detection immunoassays.

As a measure to prevent prosthetic joint infection, a number of immunoassays are available to assist in the early detection of infections out of which, lateral flow multiplex detection immunoassay is at the forefront in terms of adoption due to the low-costs, speed, and simplicity.

Multiplex Detection Immunoassays Market: Prominent Countries

North America held a major share of the global multiplex detection immunoassays market in 2019. Highly structured healthcare industry, presence of key players, and growth strategies adopted by these players are the major factors driving the multiplex detection immunoassays market in the region. Rise in awareness about benefits of procedures and increase in healthcare expenditure propel the multiplex detection immunoassays market in North America.

Asia Pacific held the second largest share of the global multiplex detection immunoassays market in 2019. The multiplex detection immunoassays market in Asia Pacific is driven by the rise in prevalence of chronic diseases and a well-developed healthcare sector. The multiplex detection immunoassays market in Asia Pacific is likely to grow at a rapid pace during the forecast period. Increase in product approvals, rise in prevalence of cardiovascular diseases, and surge in awareness leading to routine checkups and diagnosis are the major factors projected to augment the multiplex detection immunoassays market in Asia Pacific.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share.Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Significant Market Participants Operational in the Multiplex Detection Immunoassays Market are:

The global multiplex detection immunoassays market include Hoffmann-La Roche Ltd., QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories, Thermo Fisher Scientific, Luminex Corporation, and Becton, Dickinson and Company.

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects includingproduct type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2030 and covers subsequent region in its scope:

Global Multiplex Detection Immunoassays Market: Segmentation
Multiplex Detection Immunoassays Market, by Assay Type